Niall Johnson, consultant
Jerry Justin, senior director of manufacturing operations, Shire Human Genetic Therapies
Robert Kamen, board member, Lycera
Nancy Kaplan, city councilor, Burlington VT [Added: 12:20 pm, 8/12/10]
Randal Kaufman, professor of biological chemistry and internal medicine, University of Michigan
Bob Kay, president and CEO, Origen Therapeutics
Ellen Keenan, senior administrative specialist, Pfizer (retiring April 1, 2010) [Added: 12:40 pm, 3/25/10]
Brian Kelley, vice president of bioprocess development, Genentech
Rich Kenley, CEO, Advantar Laboratories
Tim Keutzer, director of project management, Cubist Pharmaceuticals [Added: 9 am, 3/24/10]
Neil Kirby, CEO, Edimer Pharmaceuticals
Bob Kitchen, principle research scientist I, analytical research and development, Pfizer [Added: 6:30 pm, 3/31/10]
Jeanette Kohlbrenner, vice president of human resources, Infinity Pharmaceuticals
Mick Koplove, retired [Added: 6:40 pm, 7/23/10]
John Knopf, founder and CEO, Acceleron Pharma
Maryann Krane, regulatory consultant, RRD International
Cathy Lagana, quality assurance metrology engineer, Boston Analytical
Tina Lampropoulos, manager, regulatory publishing, Shire Human Genetic Therapies
Toni LaPorte, vendor manager, Biogen Idec [Added: 11:30 am, 3/2/2011]
Glenn Larsen, chief operating officer, Hydra Biosciences
Peter Lasky, senior vice president of human resources, Shire Pharmaceuticals [Added: 9 am, 3/24/10]
Ed LaVallie, associate director, global biotherapeutic technologies, Pfizer [Added, 3:10 pm, 7/27/10]
Dan Lavin, senior principal process engineer, Parsons
Steven Lazar, principal, SRL Patents & Licensing
Bruce Leicher, senior vice president and general counsel, Momenta Pharmaceuticals
Patricia Lewis, biotech/pharma consultant
Jian-Liang Li, manager, bioinformatics, Sanford Burnham Medical Research Institute [Added: 10:30 am, 3/9/11]
Melinda Lindquist, president, InforMEDical Communications
Vincent Ling, head of biological sciences, Neurotech [Added: 9:30 am, 1/24/11]
Jay Lochhead, director of manufacturing, Amgen [Added: 6:30 pm, 3/23/10]
William Lonergan, security consultant, owner, Lighthouse Security Consulting [Added: 10:10 am, 3/23/10]
Andy Long, senior scientist III, immunoscience pharmacology, Abbott Laboratories. [Added: 1:50 pm, 7/23/10]
Trish Lowden, principal research associate, Acceleron Pharma [Added: 5:30 pm, 5/19/10]
Tom Maniatis, professor of molecular and cellular biology, Harvard University, co-founder Sirtris Pharmaceuticals
Istvan Mazsaroff, scientific director, Taligen Therapeutics
Jim McColgan, associate director, pilot lab and production operations, Pfizer Global Manufacturing [Added: 7:45 pm, 3/23/10]
John McCoy, chief scientific officer, Glycosyn
Pamela McMahon, associate director, Institute for Technology Assessment, Massachusetts General Hospital [Added: 8/27/12]
David Merberg, associate director, knowledge management, Vertex Pharmaceuticals
Janet Judd Merrill, executive sales representative, molecular & cell biology systems, Life Technologies [Added: 11:05 am, 4/7/10]
Deborah Meshulam, director of process science and engineering, ImmunoGen
Rachel Meyers, senior director, RNAi lead development, Alnylam Pharmaceuticals
Stephen Meyler, director of portfolio and project Management, Pfizer BioTherapeutics [Added: 6:40 pm, 9/27/10]
Carol Miceli, senior manager, investor relations, Amag Pharmaceuticals
Clare Midgley, consultant, Denneen & Company
